INVESTOR PRESENTATION

OCTOBER 2026

SOFTWARE. AI VISION. ROBOTICS.

AI and robotics

for healthcare.

Starting with Eagle Eye.

Supply visibility for hospital teams.

STERIX / CONFIDENTIAL

October 2026

RAISING

$6M

Build STERIX. Advance Eagle Eye.

investors@sterix.us

Company vision · Concept illustration

24 months to validate Eagle Eye at customer sites,

fund first deployments and build the core STERIX team.

02

EAGLE EYE / VISION-BASED INVENTORY

Eagle Eye turns movement into inventory intelligence.

01

Track

Two-camera monitoring.

Configured box positions.

02

Detect

Removals and returns.

Recorded as events.

03

Update

Inventory counts.

Timestamp + camera.

04

Notify

Low-stock alerts.

Daily / weekly reports.

TRACKED CAMERA VIEW

COUNT UPDATE / TEST MODE

LOW-STOCK ALERT / TEST MODE

EVENT HISTORY / TEST MODE

Company-reported progress: concept / prototype / case study / pilot LOI signed July 31, 2026.

Source: Bhargav’s GUI Walkthrough, 15 Sep 2026. Count and alert examples are demonstrations in test mode.

STERIX / CONFIDENTIAL

October 2026

03

THE OPPORTUNITY / FROM COST TO ACTION

Turn supply data into better replenishment.

$5.7T

U.S. healthcare spending

2025 CMS projection

$350B

Supply spending

Management scenario input

15–30%

Assumed waste rate

Management scenario input

$50–100B

Illustrative annual

supply-waste opportunity

Management scenario

Eagle Eye supplies the information to act.

Know what’s there.

Track configured positions

and supply movement.

Know what needs attention.

Flag low stock and record

removals and returns.

Plan replenishment.

Use counts, alerts and reports

to guide staff decisions.

Intended benefit: less manual checking and better replenishment decisions.

Measure in customer trials: staff time, stockouts and avoidable supply waste.

Scenario: $350B × 15–30% = $52.5–105B, rounded. Supply-spend and waste-rate inputs require validation.

Healthcare total: CMS, June 2026. These are market figures and assumptions, not measured Eagle Eye savings.

STERIX / CONFIDENTIAL

October 2026

CURRENT APPLICATION / PLANNED PLATFORM

EAGLE EYE · CURRENT

Observe → Report → Review

STERIX CONTROL · PLANNED

Assign → Resolve → Verify

ROBOT OPERATIONS · FUTURE

The same record, extended to

authorized physical work.

CONCEPT INTERFACE / ILLUSTRATIVE DATA

Current scope: presence reporting. Interface is illustrative, not a live product.

STERIX / THE SOFTWARE

From observation to accountable action

From visibility to coordinated action.

04

STERIX MEDICAL ROBOTICS

05

EAGLE EYE / INTELLECTUAL PROPERTY

Protecting the technology behind Eagle Eye.

Patent pending

EAGLE EYE / AI VISION CONCEPT

STERIX / CONFIDENTIAL

October 2026

FUTURE CONCEPTS / DEVELOPMENT HORIZON

MOBILE OBSERVATION / CONCEPT

SCOUT

Mobile observation. Findings for

staff review.

INSPECTION + HANDLING / CONCEPT

SteriSight / TrayGuard

Inspection and handling. Human

release.

SCREENING / CONCEPT

HEALTHPOD

Guided screening. Clinician review.

LONG-TERM / RESEARCH DIRECTION

SURGICAL RESEARCH

Separate development and funding

decision.

Concept visualizations, not current prototypes. Eagle Eye is the year-one focus; surgical research is outside this program.

STERIX / FUTURE CONCEPTS

Limited feasibility, not funded launches

Eagle Eye is the beginning.

FUTURE CONCEPTS · SEPARATE DEVELOPMENT DECISIONS

06

PROPOSED COMMERCIAL MODEL

Software and support.

Recurring revenue.

PROPOSED ANNUAL PRICE

$60K

per scoped site / year

Defined coverage

Agreed locations and supply categories.

Software + support

Daily reporting, user access and service scope.

Implementation priced separately

Cameras, installation, integration and evaluation.

Buyer-value test: staff time released, net of review and delivery costs.

Proposed pricing; willingness to pay unvalidated. Hardware excluded from recurring revenue.

STERIX / THE BUSINESS MODEL

Commercial evidence before commercial scale

07

THE TEAM / CLEAR RESPONSIBILITY

Hospital experience. Engineering.

Company-building.

FIONA BASA-REYES

CHIEF EXECUTIVE OFFICER

Former hospital CEO. Buyer discovery, workflow

and evaluation protocol.

CUSTOMER & WORKFLOW EVIDENCE

GURDEEP SINGH

CHIEF TECHNOLOGY OFFICER

Manufacturing and automation. Product

engineering and deployment architecture.

ENGINEERING & DELIVERY EVIDENCE

ALBERT MIZUNO

CHIEF STRATEGY OFFICER

Strategy, product vision and design.

Partnerships, user experience and AI-enabled

workflows.

STRATEGY, DESIGN & AI

PLANNED BENCH

Vision/software engineering · commercial leadership · finance · deployment and support.

STERIX / THE TEAM

Clinical context meets engineering discipline

08

09

EXECUTION / 24-MONTH PLAN

From validation to repeatable deployment.

01

MONTHS 1–6

Validate.

Named sponsor.

Agreed baseline and results.

02

MONTHS 7–12

Convert.

Security and procurement.

First paid service.

03

MONTHS 13–18

Repeat.

Next location.

Measured delivery costs.

04

MONTHS 19–24

Scale.

Retention and economics.

Evidence-led expansion.

One plan: prove the value, win the customer, repeat the delivery.

Timing runs from funding; move to the next stage when its evidence is established.

STERIX / CONFIDENTIAL

October 2026